Michael G. E. OʼRourke
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 15
- Cutaneous Melanoma Detection and Management 5
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 3
- Polyomavirus and related diseases 2
-
- Melanoma and MAPK Pathways 4
- vaccines and immunoinformatics approaches 4
- Co-authors
- JOHN R. BELL (3 shared papers)K.A.O. Ellem (7 shared papers)A.C. Green (1 shared paper)Christopher Schmidt (8 shared papers)Robert G. Bourne (1 shared paper)Catherine Lanagan (3 shared papers)David M. Purdie (2 shared papers)Suzanne Elliott (1 shared paper)
- Journals
- The Medical Journal of Australia (4 papers)Cancer Immunology Immunotherapy (2 papers)Molecular Cancer Therapeutics (1 paper)Oncogene (1 paper)Cytotherapy (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Michael G. E. OʼRourke
30 papers receiving 844 citations
Peers
Comparison fields: 5 of 71
- Oncology 467
- Immunology 297
- Dermatology 68
- Gastroenterology 21
- Molecular Biology 282
Countries citing papers authored by Michael G. E. OʼRourke
This map shows the geographic impact of Michael G. E. OʼRourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. E. OʼRourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. E. OʼRourke more than expected).
Fields of papers citing papers by Michael G. E. OʼRourke
This network shows the impact of papers produced by Michael G. E. OʼRourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. E. OʼRourke. The network helps show where Michael G. E. OʼRourke may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael G. E. OʼRourke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 153 | |
| 2 | 2004 | 141 | |
| 3 | 1997 | 76 | |
| 4 | 1985 | 65 | |
| 5 | 1986 | 64 | |
| 6 | 1988 | 53 | |
| 7 | 2007 | 44 | |
| 8 | 1999 | 36 | |
| 9 | 1993 | 31 | |
| 10 | 2012 | 25 | |
| 11 | 1984 | 22 | |
| 12 | 1986 | 19 | |
| 13 | 2006 | 18 | |
| 14 | 1982 | 15 | |
| 15 | 1984 | 13 | |
| 16 | 1986 | 13 | |
| 17 | 1990 | 12 | |
| 18 | 2011 | 12 | |
| 19 | 2000 | 12 | |
| 20 | 1986 | 12 |
About Michael G. E. OʼRourke
Michael G. E. OʼRourke is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Epidemiology, having authored 30 papers that have together received 887 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cutaneous Melanoma Detection and Management (5 papers), CAR-T cell therapy research (5 papers), Melanoma and MAPK Pathways (4 papers), vaccines and immunoinformatics approaches (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and Polyomavirus and related diseases (2 papers). The work is most often cited by research in Oncology (467 citations), Immunology (297 citations), Dermatology (68 citations), Gastroenterology (21 citations) and Molecular Biology (282 citations). Michael G. E. OʼRourke has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include JOHN R. BELL, K.A.O. Ellem, A.C. Green, Christopher Schmidt, Robert G. Bourne, Catherine Lanagan, David M. Purdie, Suzanne Elliott, Jie Yang and Peter G. Parsons. Their work appears in journals such as The Medical Journal of Australia, Cancer Immunology Immunotherapy, Molecular Cancer Therapeutics, Oncogene and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.